Skip to main content
PolicySpeak
← All files
FAS

France Assos Santé

NGO · France · EU Transparency Register 618965529397-10

1
position filed
in the 326 files tracked
1
legislative file
of 326 tracked
1
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 784 non-governmental organisations on this site, they rank #612 by legislative files engaged — a count of participation, not a measure of influence.

0.5
declared lobbying FTE
self-declared
—
declared costs / yr (floor)
1
EP accreditations
as declared to the register
2017
in the register since

Declares membership of

  • EPF: https://www.eu-patient.eu/ (adhésion en attente de validation par l'Assemblée générale)
  • The European Alliance for Responsible R&D and Affordable Medicines: http://medicinesalliance.eu/

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).

Register category
Non-governmental organisations
Head office
Paris, France

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track France in PolicySpeak: request access →

Work at France Assos Santé? so we know who speaks for it.

Follow the file France Assos Santé engages with

One email on Tuesdays when a new position is filed on this file, from France Assos Santé or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

France Assos Santé filed 1 position on 31 Jul 2026, across 1 of the 326 legislative files tracked here, attaching a full position paper 1 time.

What they argued

European Biotech Actfiled 31 Jul 2026PDFsource

1. An unbalanced text to the detriment of public health and patients’ interests. Strengthening the competitiveness of the health biotechnology sector appears to be the sole objective of the Regulation. There is a need for clear prioritisation of public health objectives.

Filed in French · English published by the European Commission

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Is this your organization?

Everything on this page comes from France Assos Santé’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.